Boston Scientific Corp (BSX)vsMonster Beverage Corp (MNST)
BSX
Boston Scientific Corp
$53.93
-4.67%
HEALTHCARE · Cap: $84.08B
MNST
Monster Beverage Corp
$86.29
+13.58%
CONSUMER DEFENSIVE · Cap: $84.38B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 149% more annual revenue ($20.61B vs $8.29B). MNST leads profitability with a 23.0% profit margin vs 17.3%. BSX appears more attractively valued with a PEG of 0.68. BSX earns a higher WallStSmart Score of 71/100 (B).
BSX
Strong Buy71
out of 100
Grade: B
MNST
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-22.6%
Fair Value
$46.16
Current Price
$53.93
$7.77 premium
Margin of Safety
+70.6%
Fair Value
$274.97
Current Price
$86.29
$188.68 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Strong operational efficiency at 20.6%
Strong operational efficiency at 31.3%
Earnings expanding 66.6% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 27 in profit
Keeps 23 of every $100 in revenue as profit
Areas to Watch
No major concerns identified
Expensive relative to growth rate
Trading at 10.2x book value
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : MNST
The strongest argument for MNST centers on Operating Margin, EPS Growth, Altman Z-Score. Profitability is solid with margins at 23.0% and operating margin at 31.3%. Revenue growth of 17.6% demonstrates continued momentum.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Bear Case : MNST
The primary concerns for MNST are PEG Ratio, Price/Book, P/E Ratio. A P/E of 41.7x leaves little room for execution misses.
Key Dynamics to Monitor
BSX profiles as a mature stock while MNST is a growth play — different risk/reward profiles.
BSX carries more volatility with a beta of 0.62 — expect wider price swings.
MNST is growing revenue faster at 17.6% — sustainability is the question.
MNST generates stronger free cash flow (584M), providing more financial flexibility.
Bottom Line
BSX scores higher overall (71/100 vs 68/100), backed by strong 17.3% margins and 11.6% revenue growth. MNST offers better value entry with a 70.6% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Monster Beverage Corp
CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA
Monster Beverage Corporation is an American beverage company that manufactures energy drinks including Monster Energy, Relentless and Burn.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?